FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002579084> ?p ?o ?g. }

• W2002579084 endingPage "25804" @default.
• W2002579084 startingPage "25798" @default.
• W2002579084 abstract "To identify the residues involved in substrate recognition by recently cloned vesicular monoamine transporters (VMAT1 and VMAT2), we have mutagenized the conserved residues in a cytoplasmic loop between transmembrane domains two and three of VMAT2. Although studies of related bacterial antibiotic resistance proteins indicate an important functional role for this region, we found no effect of these mutations on VMAT2 activity. However, replacement of aspartate 33 in the first predicted transmembrane domain with an asparagine (D33N) eliminates transport. D33N shows normal levels of expression and normal binding at equilibrium to the potent inhibitor reserpine. However, in contrast to wild-type VMAT2, serotonin inhibits reserpine binding to D33N very poorly, indicating a specific defect in substrate recognition. Replacement of three serine residues in transmembrane domain three with alanine (Stmd3A) shows a similarly selective but even more profound defect in substrate recognition. The results suggest that by analogy to receptors and plasma membrane transporters for monoamines, the cationic amino group of the ligand interacts with an aspartate in the first transmembrane domain of VMAT2 and hydroxyl groups on the catechol or indole ring interact with a group of serines in the third transmembrane domain. Importantly, D33N and Stmd3A retain coupling to the proton electrochemical gradient as measured by the ΔμH+-induced acceleration of reserpine binding. This indicates that substrate recognition can be separated from coupling to the driving force. To identify the residues involved in substrate recognition by recently cloned vesicular monoamine transporters (VMAT1 and VMAT2), we have mutagenized the conserved residues in a cytoplasmic loop between transmembrane domains two and three of VMAT2. Although studies of related bacterial antibiotic resistance proteins indicate an important functional role for this region, we found no effect of these mutations on VMAT2 activity. However, replacement of aspartate 33 in the first predicted transmembrane domain with an asparagine (D33N) eliminates transport. D33N shows normal levels of expression and normal binding at equilibrium to the potent inhibitor reserpine. However, in contrast to wild-type VMAT2, serotonin inhibits reserpine binding to D33N very poorly, indicating a specific defect in substrate recognition. Replacement of three serine residues in transmembrane domain three with alanine (Stmd3A) shows a similarly selective but even more profound defect in substrate recognition. The results suggest that by analogy to receptors and plasma membrane transporters for monoamines, the cationic amino group of the ligand interacts with an aspartate in the first transmembrane domain of VMAT2 and hydroxyl groups on the catechol or indole ring interact with a group of serines in the third transmembrane domain. Importantly, D33N and Stmd3A retain coupling to the proton electrochemical gradient as measured by the ΔμH+-induced acceleration of reserpine binding. This indicates that substrate recognition can be separated from coupling to the driving force." @default.
• W2002579084 created "2016-06-24" @default.
• W2002579084 creator A5019516255 @default.
• W2002579084 creator A5019625019 @default.
• W2002579084 creator A5027616900 @default.
• W2002579084 creator A5087106927 @default.
• W2002579084 date "1995-10-01" @default.
• W2002579084 modified "2023-09-30" @default.
• W2002579084 title "Identification of Residues Involved in Substrate Recognition by a Vesicular Monoamine Transporter" @default.
• W2002579084 cites W1482148559 @default.
• W2002579084 cites W1493753651 @default.
• W2002579084 cites W1495897262 @default.
• W2002579084 cites W1514724839 @default.
• W2002579084 cites W1532704140 @default.
• W2002579084 cites W1543135651 @default.
• W2002579084 cites W1552189630 @default.
• W2002579084 cites W1561081856 @default.
• W2002579084 cites W1581548318 @default.
• W2002579084 cites W1598364670 @default.
• W2002579084 cites W1601928222 @default.
• W2002579084 cites W1633206839 @default.
• W2002579084 cites W1761725356 @default.
• W2002579084 cites W1872020906 @default.
• W2002579084 cites W1923591030 @default.
• W2002579084 cites W1935132610 @default.
• W2002579084 cites W1966439724 @default.
• W2002579084 cites W1971434876 @default.
• W2002579084 cites W1975701282 @default.
• W2002579084 cites W1985215335 @default.
• W2002579084 cites W1988652098 @default.
• W2002579084 cites W1993534035 @default.
• W2002579084 cites W1997399405 @default.
• W2002579084 cites W1998478437 @default.
• W2002579084 cites W1999434743 @default.
• W2002579084 cites W2004714532 @default.
• W2002579084 cites W2006427869 @default.
• W2002579084 cites W2010595129 @default.
• W2002579084 cites W2013529541 @default.
• W2002579084 cites W2023166473 @default.
• W2002579084 cites W2028818514 @default.
• W2002579084 cites W2032554597 @default.
• W2002579084 cites W2032965748 @default.
• W2002579084 cites W2034883490 @default.
• W2002579084 cites W2036931150 @default.
• W2002579084 cites W2044095344 @default.
• W2002579084 cites W2054576645 @default.
• W2002579084 cites W2055939533 @default.
• W2002579084 cites W2058252407 @default.
• W2002579084 cites W2060913542 @default.
• W2002579084 cites W2063752616 @default.
• W2002579084 cites W2086170256 @default.
• W2002579084 cites W2104831013 @default.
• W2002579084 cites W2138270253 @default.
• W2002579084 cites W2145533695 @default.
• W2002579084 cites W2147209369 @default.
• W2002579084 cites W2195565602 @default.
• W2002579084 cites W4231780504 @default.
• W2002579084 doi "https://doi.org/10.1074/jbc.270.43.25798" @default.
• W2002579084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7592763" @default.
• W2002579084 hasPublicationYear "1995" @default.
• W2002579084 type Work @default.
• W2002579084 sameAs 2002579084 @default.
• W2002579084 citedByCount "75" @default.
• W2002579084 countsByYear W20025790842014 @default.
• W2002579084 countsByYear W20025790842015 @default.
• W2002579084 countsByYear W20025790842016 @default.
• W2002579084 countsByYear W20025790842018 @default.
• W2002579084 countsByYear W20025790842019 @default.
• W2002579084 countsByYear W20025790842020 @default.
• W2002579084 countsByYear W20025790842023 @default.
• W2002579084 crossrefType "journal-article" @default.
• W2002579084 hasAuthorship W2002579084A5019516255 @default.
• W2002579084 hasAuthorship W2002579084A5019625019 @default.
• W2002579084 hasAuthorship W2002579084A5027616900 @default.
• W2002579084 hasAuthorship W2002579084A5087106927 @default.
• W2002579084 hasBestOaLocation W20025790841 @default.
• W2002579084 hasConcept C118892022 @default.
• W2002579084 hasConcept C170493617 @default.
• W2002579084 hasConcept C185592680 @default.
• W2002579084 hasConcept C187714386 @default.
• W2002579084 hasConcept C24530287 @default.
• W2002579084 hasConcept C2775864247 @default.
• W2002579084 hasConcept C2776291748 @default.
• W2002579084 hasConcept C515207424 @default.
• W2002579084 hasConcept C55493867 @default.
• W2002579084 hasConcept C86803240 @default.
• W2002579084 hasConceptScore W2002579084C118892022 @default.
• W2002579084 hasConceptScore W2002579084C170493617 @default.
• W2002579084 hasConceptScore W2002579084C185592680 @default.
• W2002579084 hasConceptScore W2002579084C187714386 @default.
• W2002579084 hasConceptScore W2002579084C24530287 @default.
• W2002579084 hasConceptScore W2002579084C2775864247 @default.
• W2002579084 hasConceptScore W2002579084C2776291748 @default.
• W2002579084 hasConceptScore W2002579084C515207424 @default.
• W2002579084 hasConceptScore W2002579084C55493867 @default.
• W2002579084 hasConceptScore W2002579084C86803240 @default.
• W2002579084 hasIssue "43" @default.
• W2002579084 hasLocation W20025790841 @default.

• next